Zurich Cantonal Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,671
| Closed | -$713K | – | 2896 |
|
|
2021
Q4 | $713K | Buy |
7,671
+1,545
| +25% | +$102K | ﹤0.01% | 1202 |
|
|
2021
Q3 | $365K | Hold |
6,126
| – | – | ﹤0.01% | 1500 |
|
|
2021
Q2 | $418K | Sell |
6,126
-566
| -8% | -$36.9K | ﹤0.01% | 1336 |
|
|
2021
Q1 | $464K | Sell |
6,692
-1,225
| -15% | -$94.3K | ﹤0.01% | 1277 |
|
|
2020
Q4 | $608K | Buy |
7,917
+1,257
| +19% | +$94.2K | ﹤0.01% | 1170 |
|
|
2020
Q3 | $498K | Buy |
6,660
+558
| +9% | +$37.2K | ﹤0.01% | 1099 |
|
|
2020
Q2 | $384K | Buy |
6,102
+2,239
| +58% | +$123K | ﹤0.01% | 1141 |
|
|
2020
Q1 | $162K | Buy |
3,863
+501
| +15% | +$23K | ﹤0.01% | 1325 |
|
|
2019
Q4 | $153K | Buy |
3,362
+340
| +11% | +$16.1K | ﹤0.01% | 1482 |
|
|
2019
Q3 | $138K | Hold |
3,022
| – | – | ﹤0.01% | 1446 |
|
|
2019
Q2 | $177K | Hold |
3,022
| – | – | ﹤0.01% | 1294 |
|
|
2019
Q1 | $135K | Sell |
3,022
-528
| -15% | -$24.2K | ﹤0.01% | 1399 |
|
|
2018
Q4 | $138K | Buy |
3,550
+453
| +15% | +$17.8K | ﹤0.01% | 1412 |
|
|
2018
Q3 | $143K | Hold |
3,097
| – | – | ﹤0.01% | 1499 |
|
|
2018
Q2 | $135K | Buy |
3,097
+941
| +44% | +$40.4K | ﹤0.01% | 1488 |
|
|
2018
Q1 | $85K | Hold |
2,156
| – | – | ﹤0.01% | 1699 |
|
|
2017
Q4 | $73K | Buy |
2,156
+1,273
| +144% | +$36.3K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $23K | Hold |
883
| – | – | ﹤0.01% | 2220 |
|
|
2017
Q2 | $15K | Hold |
883
| – | – | ﹤0.01% | 2343 |
|
|
2017
Q1 | $13K | Hold |
883
| – | – | ﹤0.01% | 2436 |
|
|
2016
Q4 | $13K | Hold |
883
| – | – | ﹤0.01% | 2395 |
|
|
2016
Q3 | $15K | Hold |
883
| – | – | ﹤0.01% | 2330 |
|
|
2016
Q2 | $15K | Hold |
883
| – | – | ﹤0.01% | 2239 |
|
|
2016
Q1 | $17K | Hold |
883
| – | – | ﹤0.01% | 2164 |
|
|
2015
Q4 | $17K | Buy |
883
+592
| +203% | +$12.1K | ﹤0.01% | 2190 |
|
|
2015
Q3 | $6K | Buy |
291
+116
| +66% | +$3.94K | ﹤0.01% | 2371 |
|
|
2015
Q2 | $8K | Hold |
175
| – | – | ﹤0.01% | 1572 |
|
|
2015
Q1 | $8K | Buy |
+175
| New | +$8.13K | ﹤0.01% | 1551 |
|
|
2014
Q1 | – | Sell |
-5,000
| Closed | -$293K | – | 1001 |
|
|
2013
Q4 | $293K | Sell |
5,000
-3,000
| -38% | -$157K | 0.01% | 769 |
|
|
2013
Q3 | $422K | Hold |
8,000
| – | – | 0.01% | 650 |
|
|
2013
Q2 | $616K | Buy |
+8,000
| New | +$653K | 0.02% | 532 |
|
Zurich Cantonal Bank's ARNA Position: Q1 2022 in Review
Zurich Cantonal Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 7,671 shares — an estimated $713K sold.
Zurich Cantonal Bank first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $713K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Zurich Cantonal Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Zurich Cantonal Bank sold 7,671 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $713K.
- Zurich Cantonal Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- Zurich Cantonal Bank's Arena Pharmaceuticals Inc position peaked at $713K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.